Gellini M - Search Results

Year	Number of Results
2006	1
2008	2
2009	1
2013	2
2014	1
2015	1
2019	2
2021	3
2024	0

1

Impact of gender on 10-year outcome after coronary artery bypass grafting.

Barili F, D'Errigo P, Rosato S, Biancari F, Forti M, Pagano E, Parolari A, Gellini M, Badoni G, Seccareccia F. Barili F, et al. Among authors: gellini m. Interact Cardiovasc Thorac Surg. 2021 Oct 4;33(4):510-517. doi: 10.1093/icvts/ivab125. Interact Cardiovasc Thorac Surg. 2021. PMID: 34000041 Free PMC article.

2

[The PRIORITY study - PRedictIng long term Outcomes afteR Isolated coronary arTery bypass surgerY].

Barili F, D'Errigo P, Rosato S, Pagano E, Forti M, Biancari F, Evangelista A, D'Ovidio M, Gellini M, Borsellino L, Grossi C, Rosato F, Parolari A, Seccareccia F. Barili F, et al. Among authors: gellini m. G Ital Cardiol (Rome). 2021 Apr;22(4):327-331. doi: 10.1714/3574.35579. G Ital Cardiol (Rome). 2021. PMID: 33783453 Italian.

3

Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8⁺ T lymphocyte exhaustion.

Ascione A, Arenaccio C, Mallano A, Flego M, Gellini M, Andreotti M, Fenwick C, Pantaleo G, Vella S, Federico M. Ascione A, et al. Among authors: gellini m. BMC Biotechnol. 2019 Oct 17;19(1):67. doi: 10.1186/s12896-019-0559-x. BMC Biotechnol. 2019. PMID: 31623599 Free PMC article.

4

Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity.

Flego M, Frau A, Accardi L, Mallano A, Ascione A, Gellini M, Fanunza E, Vella S, Di Bonito P, Tramontano E. Flego M, et al. Among authors: gellini m. BMC Biotechnol. 2019 Sep 5;19(1):64. doi: 10.1186/s12896-019-0554-2. BMC Biotechnol. 2019. PMID: 31488108 Free PMC article.

5

Isolation and preliminary characterization of a human 'phage display'-derived antibody against neural adhesion molecule-1 antigen interfering with fibroblast growth factor receptor-1 binding.

Flego M, Colotti G, Ascione A, Dupuis ML, Petrucci E, Riccioni R, Andreotti M, Raggi C, Boe A, Barca S, Gellini M, Vella S, Mallano A. Flego M, et al. Among authors: gellini m. Hum Antibodies. 2021;29(1):63-84. doi: 10.3233/HAB-200431. Hum Antibodies. 2021. PMID: 33164927

6

Human monoclonal antibodies in single chain fragment variable format with potent neutralization activity against influenza virus H5N1.

Ascione A, Capecchi B, Campitelli L, Imperiale V, Flego M, Zamboni S, Gellini M, Alberini I, Pittiglio E, Donatelli I, Temperton NJ, Cianfriglia M. Ascione A, et al. Among authors: gellini m. Antiviral Res. 2009 Sep;83(3):238-44. doi: 10.1016/j.antiviral.2009.05.005. Epub 2009 May 27. Antiviral Res. 2009. PMID: 19481117

7

CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.

Guerzoni C, Fiori V, Terracciano M, Manara MC, Moricoli D, Pasello M, Sciandra M, Nicoletti G, Gellini M, Dominici S, Chiodoni C, Fornasari PM, Lollini PL, Colombo MP, Picci P, Cianfriglia M, Magnani M, Scotlandi K. Guerzoni C, et al. Among authors: gellini m. Clin Cancer Res. 2015 Jan 1;21(1):146-56. doi: 10.1158/1078-0432.CCR-14-0492. Epub 2014 Dec 11. Clin Cancer Res. 2015. PMID: 25501132

8

Generation and characterization of a human single-chain fragment variable (scFv) antibody against cytosine deaminase from yeast.

Mallano A, Zamboni S, Carpinelli G, Santoro F, Flego M, Ascione A, Gellini M, Tombesi M, Podo F, Cianfriglia M. Mallano A, et al. Among authors: gellini m. BMC Biotechnol. 2008 Sep 10;8:68. doi: 10.1186/1472-6750-8-68. BMC Biotechnol. 2008. PMID: 18783590 Free PMC article.

9

Genetic construction, expression, and characterization of a single chain anti-CEA antibody fused to cytosine deaminase from yeast.

Zamboni S, Mallano A, Flego M, Ascione A, Dupuis ML, Gellini M, Barca S, Cianfriglia M. Zamboni S, et al. Among authors: gellini m. Int J Oncol. 2008 Jun;32(6):1245-51. doi: 10.3892/ijo_32_6_1245. Int J Oncol. 2008. PMID: 18497986

10

Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells.

Gellini M, Ascione A, Flego M, Mallano A, Dupuis ML, Zamboni S, Terrinoni M, D'Alessio V, Manara MC, Scotlandi K, Picci P, Cianfriglia M. Gellini M, et al. Curr Pharm Biotechnol. 2013;14(4):449-63. doi: 10.2174/1389201011314040011. Curr Pharm Biotechnol. 2013. PMID: 22335486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year